Acadia Pharmaceuticals Inc.
$4.96B- Market cap
- $4.83B
- Debt
- +$306.51M
- Cash
- −$177.70M
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.92x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · current priceP/S 4.51x
$28.04Latest market snapshot
Implied fair value · at HPE's multiple
$12.5255.3% below market
6.22 ACAD revenue / share×2.01x HPE P/S=$12.52
Market $28.04Implied $12.52
HPE · current priceP/S 2.01x
$52.02Latest market snapshot
Implied fair value · at ACAD's multiple
$116.49123.9% above market
25.84 HPE revenue / share×4.51x ACAD P/S=$116.49
Market $52.02Implied $116.49